Novozymes A/S (NVZMY) has a profit margin of -5.89%, below the sector sector average of 13.23%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Novozymes A/S posts a profit margin of -5.89% as of June 2026. That compares with -1.02% in the prior-year period — down 478.8% year over year. That is below the sector sector average of 13.23%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Novozymes A/S's profit margin was -1.02%. The latest reading is -5.89% — a 478.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a profit margin near 13.23% is typical. Novozymes A/S's -5.89% is lower that level. That is roughly 144.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Novozymes A/S's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -5.89% as of June 2026; use YoY and peer views to separate noise from signal.
Context for NVZMY's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.23%), and (3) consistency with growth and profitability. This page covers the first two; Novozymes A/S's other metric pages and overview cover the third.